Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Aerogel, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window.
Last mentioned: Aug 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Aerogel, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. The 5 average consequence score is below the beat benchmark of 5.2 in the same window. Dr Niall Kent appears in 1 tracked Healthcare story from August 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 40 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Dr Niall Kent. Shared-story counts are live from our verified record — not editorial picks.
A 10-year development effort by NHS maxillofacial surgeon Dr Niall Kent produced Ozen, an aerogel-based toothpaste that seals dentinal channels and releases remineralizing ions — the first new sensitivity patent in nearly three decades. Claims of instant relief are winning endorsement from high-profile sports dentistry but remain unverified by published clinical trials.
Source: plymouthherald.co.uk · gazettelive.co.uk
Dr Niall Kent is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
